Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by RoyaleWithCheezon Aug 17, 2021 5:36pm
165 Views
Post# 33721099

Unfortunately

UnfortunatelyFor what it's worth, which is admittedly nothing, I do not see any significant positive catalysts for this company.

GPR84 and OXER1 may cure cancer, covid and syphilis combined but there will not be any sustained price appreciation for this company at this time.  IMO you wont see results from a phase one until close to 2024.  

4050 may have a nifty new indication, but when will you see the results of a phase 2?  Again, see you in 2024.  Remember when Galbraith was promising a 4050 phase 2 in the second half of 2020!

How much cash does Limininal have at this point?   I know it's not $160mm like some clown posted.



<< Previous
Bullboard Posts
Next >>